This compound is a chemical compound used as a pharmaceutical intermediate in the manufacturing of active pharmaceutical ingredients. It features an aromatic ether and a tertiary amine functional group.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 83015-25-2
Rac N-Methyl Atomoxetine Oxalate
pharmaceutical intermediate
N-Nitroso-Atomoxetine
pharmaceutical raw material
N-{[2-Fluoro-6-(trifluoromethyl)phenyl]methyl}urea
pharmaceutical intermediate
1-{[2-Fluoro-6-(trifluoromethyl)phenyl]methyl}-6-methylpyrimidine-2,4(1H,3H)-dione
pharmaceutical intermediate
5-bromo-1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
pharmaceutical intermediate
1,1-Dimethylethyl N-[(1R)-2-[5-bromo-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]carbamate
pharmaceutical intermediate
N,N-dimethyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine
UCPQMRYBCNDVHU-UHFFFAOYSA-N
CC1=CC=CC=C1OC(CCN(C)C)C2=CC=CC=C2
—